Guess they will do interim analysis when they have
Post# of 148184
(Total Views: 625)
Posted On: 07/01/2020 1:13:36 PM
Guess they will do interim analysis when they have half of the patients, ~180, enrolled. Should be doable by end of July... 120 enrolled already, and casenumbers spiking...
Much better chance getting a stat sig p-value and/or halt for efficacy with n=180.
A 33% death rate in the placebo group and 20% death rate in the leronlimab arm would yield p=0.03. That's doable.
Much better chance getting a stat sig p-value and/or halt for efficacy with n=180.
A 33% death rate in the placebo group and 20% death rate in the leronlimab arm would yield p=0.03. That's doable.
(3)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼